Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors.

Fiche du document

Date

2000

Type de document
Périmètre
Langue
Identifiants
Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/S0022-1759(99)00239-2

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/10725460

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/0022-1759

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_69A67AAF39A67

Licences

info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer



Sujets proches En

Melting

Citer ce document

N. Holler et al., « Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors. », Serveur académique Lausannois, ID : 10.1016/S0022-1759(99


Métriques


Partage / Export

Résumé 0

TNF receptor family members fused to the constant domain of immunoglobulin G have been widely used as immunoadhesins in basic in vitro and in vivo research and in some clinical applications. In this study, we assemble soluble, high avidity chimeric receptors on a pentameric scaffold derived from the coiled-coil domain of cartilage oligomeric matrix protein (COMP). The affinity of Fas and CD40 (but not TNFR-1 and TRAIL-R2) to their ligands is increased by fusion to COMP, when compared to the respective Fc chimeras. In functional assays, Fas:COMP was at least 20-fold more active than Fas:Fc at inhibiting the action of sFasL, and CD40:COMP could block CD40L-mediated proliferation of B cells, whereas CD40:Fc could not. In conclusion, members of the TNF receptor family can display high specificity and excellent avidity for their ligands if they are adequately multimerized.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets